GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » Purchase Of Property, Plant, Equipment

Invex Therapeutics (ASX:IXC) Purchase Of Property, Plant, Equipment : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics Purchase Of Property, Plant, Equipment?

Invex Therapeutics's purchase of property, plant, equipment for the six months ended in Dec. 2023 was A$0.00 Mil. It means Invex Therapeutics spent A$0.00 Mil on purchasing property, plant, equipment. Invex Therapeutics's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2023 ), Invex Therapeutics spent the same money on purchasing property, plant, equipment in Dec. 2023 (A$0.00 Mil).


Invex Therapeutics Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Invex Therapeutics's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invex Therapeutics Purchase Of Property, Plant, Equipment Chart

Invex Therapeutics Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Purchase Of Property, Plant, Equipment
- - - -

Invex Therapeutics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only - - - - -

Invex Therapeutics Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invex Therapeutics Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Invex Therapeutics's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Invex Therapeutics (ASX:IXC) Business Description

Industry
Traded in Other Exchanges
N/A
Address
38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008
Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its other program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.

Invex Therapeutics (ASX:IXC) Headlines

From GuruFocus

Fisher Asset Management Trims Infosys, Equinor Positions

By Tiziano Frateschi Tiziano Frateschi 02-07-2021